(ISSN 2692-9880)

Acquaint instigated an open-access peer-reviewed journal, Case Reports and Case Study (JMCRCS), aimed to publish case reports in all areas of clinical remedy that spread out the medical acquaintance. JMCRCS will publish 2 issues per month with international coverage and high-quality peer-reviewed content for the global Savant. JMCRCS fills the space between clinicians and academic experts by publishing the latest updates and significant case reports. JMCRCS is a reliable source for young medical and clinical researchers where current knowledge can be accessed and updated oneself.

Acquaint case reports and case studies cover major topics like case reports in Dermatology, Dentistry, Gastroenterology, Public health, Immunology, Community medicine, Clinical pharmacy, Diabetes case reports; Cancer case reports, Cardiology, Emergency medicine, General medicine, Hepatology, Microbiology, Pancreatology; Molecular biology, Neuroscience, Obstetrics, and Gynecology,  Surgical oncology, Nephrology, Obesity, Sleep disorders, Spinal diseases, Addiction research, Women health care, and other Surgery reports.

JMCRCS editor invites clinicians, academics, physicians, and medical experts to publish their unpublished case reports, case studies, case reviews, letters, and editorials for publication. All the submitted manuscripts will be reviewed by expert editors/reviewers within the field; all articles are published only upon acceptance by the editor and are available online for a reader, which allows free distribution, reuse, and reprint of the published content until the credit of the original content is given to the corresponding author.

Authors worldwide could submit the manuscripts through our online portal or send us an e-mail attachment to the editorial office.

Open Access Publication and Creative Commons Licensing:

This is an open-access journal, and articles are distributed under the terms of the Attribution 4.0 International (CC BY 4.0)

  • Share — copy and redistribute the material in any medium or format
  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Under the following terms:

Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Recently Published Articles


We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.

Do you have an idea or suggestion that can influence the Open Access community? Send an email to: info@acquaintjournals.info

Subscribe to our Newsletter

Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.

Quick Links

Open Access Policy
Publication Ethics and Malpractice Statement
Conflicts of Interest
Plagiarism Policy
Copyright Information
Licensing Policy
Withdrawal/Retraction Policy
Advertising Policy
Peer review Policy
Policies On Animal & Human Rights
Privacy Policy, Terms & Conditions
Complaint Policy
Archiving Policy
About Us
Recent Articles

First in Human: Redo Transapical TAVR with A Sapien 3 Ultra in an Early Degenerated Acurate Neo – A Case Report

Against All Odds: Successful Emergent Surgical Management of a Ruptured Aorto-Oesophageal Fistula – A Case Report

Four Hundred Twenty-Five Gallstones Removed Through Laparoscopic Cholecystectomy From A Single Patient: A Case Report

Treatment Outcome of Trochanteric Fracture Treated Using SIGN Hip Construct with Versus without A Highly Versatility Plate at Muhimbili Orthopaedics Institute (MOI).

Neutrophil/Lymphocyte Ratio In Patients With Type 2 Diabetes Mellitus Without Glycemic Control and Associated Risk Factors In A Second Level Hospital

Systematic Evaluation And Meta-Analysis Of The Effectiveness Of Novel Coronavirus Pneumonia Vaccine Against Omicron Mutant

An Unusual Case Of A Segmented Appendix At Diagnostic Laparoscopy For Right Iliac Fossa Pain

Antibiogram of Catheter-Associated Bacterial Pathogens in Urinary Tract Infection Among Pediatrics Patients in Pakistan

A Retrospective Cohort Study on Neurological Manifestations in Hospitalized COVID-19 Patients in a Tertiary-Care Hospital in Dubai, UAE

Successful Management of An Advanced Abdominal Pregnancy With A Viable Fetus: A Case Report


We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.

Do you have an idea or suggestion that can influence the Open Access community? Send an email to: info@acquaintjournals.info

Notice Board




Journal of Medical Case Reports and Case series [JMCRCS]- [2692-9880] (IF:1.067)
Journal of Community Medicine and Public Health Reports [JCMPHR] ISSN: 2692-9899 (IF:3.45)


Acquaint is a raised area of choice for an international community of research scholars to share their work with the global scientific community without any restrictions. We maintain superior integrity and scientific relationship with authors, researchers, and academicians. We encourage authors from every corner of the globe to submit their articles.

Our journals offer a critical stage for the universal logical community to talk and share data while publicizing research discoveries globally. Our journals include many subjects in tremendous areas that permit the researchers to publish through the open-access model. We welcome all academicians and researchers to submit their work for publication.

We welcome all academicians and analysts to submit their work for publication in our journals.

To visit our journals: click here.

Last Date for Article Submission: 31 May 2023.

Online Publication Date: within 3-4 working days upon acceptance.

For collaborations/memberships/discounts/waivers, please get in touch with us at: